With more than 15 years of experience in the biopharmaceutical industry, Pam Hill has worked in the discovery phase supporting multiple therapy areas and brought mulitple drugs into clincial studies. Hill is currently leading the Open Innovation program at AstraZeneca which has revolutionized how AstraZeneca is utilitizing open collaborations with academic and industry partners to further advance cutting edge research to bring novel therapies to patients.